Abstract
Purpose: The majority of people with schizophrenia has impaired insight, which is related to a poorer outcome. In this study, we evaluate a new psychosocial intervention ‘REFLEX’ aimed at improving insight in people with schizophrenia. REFLEX focuses on targeting stigma-sensitivity, perspective taking and self-reflection in people with schizophrenia and low insight. Primary objective is to improve insight and subsequently to improve functional outcome and symptoms. Method: A total of 121 people diagnosed with schizophrenia according to DSM IV criteria with impaired insight was included in 2012–2015 from seven sites in a multicenter randomized controlled trial. REFLEX was compared to an active control condition consisting of group-wise simplified cognitive remediation training. Primary outcome of the study were the preconditions of insight: internalized stigma, self-reflection, mental flexibility and perspective taking. Clinical insight and cognitive insight were secondary outcomes. Results: Although perspective taking, self-reflection, mental flexibility and stigma sensitivity remained unchanged after the intervention, results showed a significant improvement of clinical insight in both conditions directly after treatment (SAI-E Rater, p < .001, PANSS G12, p < .005) and at follow-up (SAI-E Rater, p < .01, SAI-E interview, p < .001, PANSS G12, p < .0001). Improvement of clinical insight directly after treatment was larger in the REFLEX condition (SAI-E Rater, p < .05). Other outcomes (self-esteem, quality of life and depression) remained unchanged. Conclusion: Though insight improved in both conditions, REFLEX was not superior to simplified drill-and-practice cognitive remediation training. Nevertheless, this study indicates that structured interventions can significantly improve insight. Further research on the underlying mechanisms of both conditions is needed, as insight is unlikely to improve spontaneously in chronic patients.
| Original language | English |
|---|---|
| Pages (from-to) | 362-369 |
| Number of pages | 8 |
| Journal | Schizophrenia Research |
| Volume | 206 |
| Early online date | 12 Nov 2018 |
| DOIs | |
| Publication status | Published - Apr 2019 |
Funding
The study was funded in part by a European Young Investigator (EURYI) Award from the European Science Foundation to AA (N.W.O. number 044035001). Other contributions (in terms of personnel involved) are from the mental health centers involved. The authors gratefully acknowledge Lentis, Groningen; University Medical Hospital Groningen (UMCG), Groningen; Department of Psychotic Disorders GGZ Drenthe, Assen; Department of Psychotic Disorders GGZ Friesland, Leeuwarden; Parnassia Psychiatric Institute, Portugaal; GGZ Centraal, Ermelo, and GGZ Noord Holland Noord, Schagen for their participation in the trial. We are indebted to all therapists (Lentis, Groningen: Ineke Koopman, MSc. Wouter Draaisma, MSc. Anneke Zijlstra. GGZ Drenthe, Assen: Ellen Horsselenberg, MSc. UCP Groningen: Han Bous, Maarten Vos, MSc. GGZ Friesland: Ronald Boonstra, MSc. Petra Schuurmans MSc. Welmoed Kostwinder MSc. Rozanne van Donkersgoed, MSc. Parnassia Den Haag: Andra Lansbergen, MSc. Esme Marques, MSc. Gitty de Haan, MSc. Bianca Raaijmakers, MSc. Sandra van der Drift, MSc. en Wies Titulaer, MSc. GGZ Noord Holland Noord: Krijn van Berkel, Marjolijn Hoekert, PhD) and to Alfred Burema (GGZ Drenthe), Leonie Bais (Neuroimaging Center UMCG, Groningen), Erna van't Hag (UCP, UMCG Groningen), Roeline Nieboer (GGZ Friesland, Leeuwarden), Wubbieke Everts, Nicky Heerings, Bertus Jeronimus, Renske Buit, Stefanie de Vries, Marthe Mekel, Charlotte Rem, Remzi Karadayi, Arjan Pijpker, Anne Kuipers, Ingrid Sibum, Maaike Tjooitink, Dianne Tijmes, Roos Temmink, Jose de Jager, Michel Gernaat, Elsa Fledderus, Milou Wiersum, Merel Prikken, Daouia Larabi, Kiki Koster and Steven de Jong (all master students of the clinical psychology track of the University of Groningen) for their help in setting up the trial and collecting the data. The study was funded in part by a European Young Investigator (EURYI) Award from the European Science Foundation to AA (N.W.O. number 044035001 ). Other contributions (in terms of personnel involved) are from the mental health centers involved.
| Funders | Funder number |
|---|---|
| GGZ Noord Holland Noord | |
| University Medical Hospital Groningen | |
| European Science Foundation | 044035001 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Awareness
- Clinical trial
- Perspective taking
- Schizophrenia
- Self-reflection
- Self-stigma
Fingerprint
Dive into the research topics of 'Social cognitive group treatment for impaired insight in psychosis: A multicenter randomized controlled trial'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver